Fujitsu and Scaleway partner to accelerate European sustainable transformation and data sovereignty with FUJITSU-MONAKA CPU-based AI inference Desember 4, 2025
NEC Orchestrating Future Fund Invests in PopID, Inc. to Accelerate Global Expansion of Biometric Payment Solutions and Launch a Strategic Collaboration Desember 4, 2025
Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI(R) (lecanemab-irmb) Maintenance Treatment in Early Alzheimer’s Disease at CTAD 2025 Desember 4, 2025
Anime Tokyo Station: Celebrating the 25th Anniversaries of Two Popular Anime with an Anniversary Joint Exhibition Starting November 15 Desember 3, 2025
NEC Launches AI Agent Service in Japan to Automate Procurement Negotiations Using AI Desember 2, 2025
Fujitsu establishes international consortium to tackle disinformation/misinformation and new AI risks Desember 2, 2025
Fujitsu achieves high-precision, long-duration molecular dynamics simulation for all-solid-state battery interphases with over 100,000 atoms Desember 1, 2025
Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials Desember 1, 2025
Fujitsu launches ‘Fujitsu Accelerator Program for SPORTS’ to create new value through Sports x Technology Desember 1, 2025
Eisai Submits New Drug Application for Subcutaneous Formulation of “LEQEMBI(R)” for the Treatment of Early Alzheimer’s Disease in Japan November 28, 2025
Sharp Wins IAM’s “Asia IP Elite 2025”, Awarded to Companies with Outstanding Intellectual Property Strategy for The Second Consecutive Year November 28, 2025
Fujitsu builds platform for NSK to create environmental value throughout the product lifecycle of bearing products November 28, 2025
Fujitsu launches Japan Edition of SAP Fioneer Cloud for Insurance, a next-generation platform supporting core business operations in the Japanese insurance industry November 28, 2025
Fujitsu and Yamaguchi University develop low-power edge computing technology for near real-time image processing on small satellites November 27, 2025
World’s first ever spiral escalator renewal project conducted at a commercial facility in Mexico November 27, 2025
Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) IQLIK(TM) (lecanemabirmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status November 26, 2025
